Yersinia enterocolitica: Difference between revisions

No edit summary
(3 intermediate revisions by 3 users not shown)
Line 7: Line 7:
*[[Abdominal Pain]]
*[[Abdominal Pain]]
*[[Fever]]
*[[Fever]]
*watery diarrhea initially, becomes bloody
*A smaller percentage will have pain and fever alone (mimicking [[Appendicitis]])
*A smaller percentage will have pain and fever alone (mimicking [[Appendicitis]])


Line 12: Line 13:
{{Diarrhea DDX}}
{{Diarrhea DDX}}


==Diagnosis==
==Evaluation==
*Stool culture


==Treatment==
==Management==
*Tends to be self limiting
*Tends to be self limiting
*IVF if needed, pain control, fever control
*Supportive care: IVF, pain control, antipyretics
*Severe disease may warrant [[ciprofloxacin]] and/or [[TMP-SMX]]
*Severe disease may warrant [[ciprofloxacin]] and/or [[TMP-SMX]]


Line 167: Line 169:
==Table Overview==
==Table Overview==
{{Clinically Relevant Bacteria}}
{{Clinically Relevant Bacteria}}
==Disposition==


==See Also==
==See Also==

Revision as of 02:04, 26 February 2018

Background

Clinical Features

Differential Diagnosis

Acute diarrhea

Infectious

Noninfectious

Watery Diarrhea

Traveler's Diarrhea

Evaluation

  • Stool culture

Management

  • Tends to be self limiting
  • Supportive care: IVF, pain control, antipyretics
  • Severe disease may warrant ciprofloxacin and/or TMP-SMX

Antibiotic Sensitivities[2]

Category Antibiotic Sensitivity
Penicillins Penicillin G R
Penicillin V R
Anti-Staphylocccal Penicillins Methicillin R
Nafcillin/Oxacillin R
Cloxacillin/Diclox. R
Amino-Penicillins AMP/Amox R
Amox-Clav I
AMP-Sulb I
Anti-Pseudomonal Penicillins Ticarcillin I
Ticar-Clav S
Pip-Tazo X1
Piperacillin S
Carbapenems Doripenem S
Ertapenem X1
Imipenem S
Meropenem X1
Aztreonam S
Fluroquinolones Ciprofloxacin S
Ofloxacin S
Pefloxacin S
Levofloxacin S
Moxifloxacin S
Gemifloxacin X1
Gatifloxacin S
1st G Cephalo Cefazolin R
2nd G. Cephalo Cefotetan I
Cefoxitin I
Cefuroxime I
3rd/4th G. Cephalo Cefotaxime S
Cefizoxime S
CefTRIAXone S
Ceftaroline X1
CefTAZidime I
Cefepime S
Oral 1st G. Cephalo Cefadroxil X1
Cephalexin X1
Oral 2nd G. Cephalo Cefaclor/Loracarbef X1
Cefproxil X1
Cefuroxime axetil X1
Oral 3rd G. Cephalo Cefixime S
Ceftibuten S
Cefpodox/Cefdinir/Cefditoren X1
Aminoglycosides Gentamicin S
Tobramycin S
Amikacin S
Chloramphenicol S
Clindamycin R
Macrolides Erythromycin R
Azithromycin R
Clarithromycin R
Ketolide Telithromycin R
Tetracyclines Doxycycline R
Minocycline R
Glycylcycline Tigecycline X1
Daptomycin R
Glyco/Lipoclycopeptides Vancomycin X1
Teicoplanin X1
Telavancin X1
Fusidic Acid R
Trimethoprim X1
TMP-SMX S
Urinary Agents Nitrofurantoin X1
Fosfomycin X1
Other Rifampin X1
Metronidazole R
Quinupristin dalfoppristin X1
Linezolid R
Colistimethate X1

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

Disposition

See Also

References

  1. Marx et al. “Cholera and Gastroenteritis caused by Noncholera Vibrio Species”. Rosen’s Emergency Medicine 8th edition vol 1 pg 1245-1246.
  2. Sanford Guide to Antimicrobial Therapy 2014